Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Androgens can cause the growth of prostate cancer cells. Drugs, such as
leuprolide, goserelin, flutamide, or bicalutamide, may stop the adrenal glands from making
androgens. Radiation therapy uses high-energy x-rays to damage tumor cells. Giving these
drugs together with radiation therapy may kill more tumor cells.
PURPOSE: This phase II trial is studying how well androgen suppression with either leuprolide
or goserelin and either flutamide or bicalutamide together with radiation therapy works in
treating patients with prostate cancer.